Cy5.5 NHS Ester (Non-Sulfonated): Applied Strategies for Advanced Near-Infrared Fluorescent Labeling

Principle and Setup: Harnessing Cy5.5 NHS Ester for Targeted Biomolecule Labeling

Cy5.5 NHS ester (non-sulfonated) is a next-generation near-infrared fluorescent dye engineered for covalent labeling of biomolecules containing primary amino groups. Leveraging its N-hydroxysuccinimide (NHS) ester chemistry, it enables stable amide bond formation with lysine residues in proteins, N-termini of peptides, and amino-modified oligonucleotides. With excitation and emission maxima at 684 nm and 710 nm respectively (excitation emission cy5.5), the dye minimizes background autofluorescence and maximizes signal-to-noise in deep-tissue and in vivo imaging workflows. Its high extinction coefficient (209,000 M⁻¹cm⁻¹) and respectable quantum yield (0.2) make it a high-performance choice for sensitive detection, whether for tumor imaging agents, fluorescent probes for biomedical research, or in vivo tumor imaging dye platforms.

Unlike sulfonated analogs, the non-sulfonated Cy5.5 NHS ester offers superior membrane permeability and labeling efficiency for hydrophobic targets or environments where charge neutrality is essential. However, its low aqueous solubility requires initial dissolution in DMSO or DMF (with a solubility of at least 35.82 mg/mL in DMSO), followed by dilution into aqueous buffers for optimal reaction with biomolecules.

Step-by-Step Workflow: Enhanced Protocols for Amino Group Labeling

1. Preparing the Labeling Reaction

• Dissolution: Accurately weigh Cy5.5 NHS ester (non-sulfonated) and dissolve in anhydrous DMSO to prepare a 10 mM stock solution. Use immediately to prevent hydrolysis.
• Target Preparation: Prepare the biomolecule (protein, peptide, or oligonucleotide) in a suitable amine-free buffer (e.g., 0.1 M sodium bicarbonate, pH 8.3). Avoid Tris or primary amines that compete for labeling.
• Reaction Setup: Add the dye stock to the biomolecule solution at a molar ratio of 3–10:1 (dye:biomolecule) for proteins or peptides. For oligonucleotides, optimize the ratio based on the number of accessible amino groups.
• Incubation: Gently mix and incubate at room temperature, protected from light, for 30–60 minutes. Reaction times can be shortened for highly reactive targets or increased for sterically hindered sites.

2. Purification and Quality Control

• Desalting: Remove excess dye using size-exclusion chromatography (e.g., Sephadex G-25) or ultrafiltration (10 kDa cutoff for proteins).
• Quantification: Measure absorbance at 684 nm to determine the degree of labeling (DOL) using the dye’s extinction coefficient. For higher accuracy, use a dual-wavelength method (protein at 280 nm, dye at 684 nm) and correct for spectral overlap.
• Storage: Store labeled conjugates at 4°C, protected from light. Avoid freeze-thaw cycles. Note that dye solutions should be used promptly after preparation; solid dye remains stable for at least 24 months at -20°C.

Advanced Applications: Comparative Advantages in Imaging and Nanoplatforms

The deployment of Cy5.5 NHS ester (non-sulfonated) as a near-infrared fluorescent dye for biomolecule labeling has catalyzed several cutting-edge research avenues:

• In Vivo Tumor and Xenograft Imaging: The dye’s deep-tissue penetration, enabled by NIR wavelengths, facilitates high-contrast optical imaging of subcutaneous and orthotopic tumors. Studies employing Cy5.5-labeled antibodies or peptides have mapped tumor boundaries and metastatic spread with remarkable clarity.
• Real-Time Tracking of Nanoplatforms: In the pivotal study Ultrasound-Triggered Biomimetic Piezo-Nanoplatforms for Non-Invasive Epilepsy Treatment, NIR-labeled nanomaterials were tracked in vivo to monitor biodistribution and neuromodulatory effects. Cy5.5 NHS ester conjugation enabled precise, non-invasive visualization and quantification of piezoelectric nanoparticles as they traversed biological barriers and localized to target tissues.
• Multiplexed Molecular and Cellular Imaging: The distinct excitation/emission profile of Cy5.5 enables panel-based flow cytometry, immunofluorescence, and western blot detection, complementing conventional fluorophores (e.g., FITC, Cy3, Cy5) while minimizing spectral overlap.
• Plasmid DNA and Oligonucleotide Labeling: As a robust plasmid DNA labeling reagent and oligonucleotide labeling dye, Cy5.5 NHS ester facilitates studies of gene delivery, nucleic acid trafficking, and molecular diagnostics.

Comparative Insights: The article Pushing the Boundaries of Translational Imaging extends these themes, offering strategic frameworks for integrating Cy5.5 NHS ester in advanced molecular imaging. In contrast, Pioneering Deep-Tissue Imaging emphasizes the unique value of Cy5.5 in exploring tumor-microbiome interactions, while Atomic Evidence for Near-Infrared Applications provides atomic-level validation of its specificity and performance. These resources collectively demonstrate how Cy5.5 NHS ester (non-sulfonated) serves as a cornerstone for next-generation biomedical research.

Troubleshooting and Optimization: Achieving Reproducible, High-Yield Labeling

Mastery of Cy5.5 NHS ester (non-sulfonated) labeling requires attention to detail at each experimental stage. Below are evidence-based troubleshooting and optimization strategies:

• Poor Solubility or Precipitation: Always dissolve the dye in DMSO or DMF before adding to aqueous buffers. Never add the dry dye directly to water-based solutions. If precipitation occurs, increase the proportion of organic co-solvent (up to 10% v/v) in the reaction mixture.
• Low Labeling Efficiency: Confirm that the target biomolecule is free from competing amines (e.g., Tris buffer). Increase the dye-to-biomolecule molar ratio or extend reaction time if steric hindrance is suspected. Freshly prepare dye stock immediately before use to minimize NHS ester hydrolysis.
• High Background or Non-Specific Binding: Perform thorough purification post-labeling. Use blocking steps or include detergent (e.g., 0.05% Tween-20) during washing for protein labeling workflows such as western blot or flow cytometry.
• Signal Instability: Protect samples from light at all times. Store the solid dye at -20°C and avoid repeated freeze-thaw cycles. Labeled conjugates should be aliquoted and stored at 4°C for short-term use.
• Quantification Artifacts: Correct for dye absorbance at 280 nm when calculating protein concentration. Use dual-wavelength absorbance measurements and empirically determine correction factors for your system.

These tips draw on best practices established in the article Next-Generation Near-Infrared Fluorescent Labeling, which further dissects the mechanistic nuances of amino group reactive fluorescent dyes.

Future Outlook: Cy5.5 NHS Ester in Next-Generation Molecular Imaging

The robust performance and versatile reactivity of Cy5.5 NHS ester (non-sulfonated) position it at the forefront of near-infrared fluorescence imaging and molecular labeling innovation. As demonstrated in recent studies on wireless neuromodulation and piezo-nanoplatform tracking (Li et al., 2025), the dye will continue to power the integration of imaging and therapy in translational research. Emerging workflows—such as multi-modal imaging of tumor xenografts, real-time monitoring of drug delivery systems, and advanced flow cytometry panel design—rely on the unique spectral and chemical properties of Cy5.5 NHS ester.

Continued optimization of conjugation chemistry, expansion into new bioconjugate classes, and synergistic use with other NIR dyes will further solidify its role as a fluorescent probe for molecular biology. APExBIO remains a trusted supplier, offering rigorous quality control and technical support to ensure researchers achieve consistent, high-impact results with this high extinction coefficient dye.

For full technical specifications, application notes, and ordering information, visit the Cy5.5 NHS ester (non-sulfonated) product page.